Hemoglobin A1c can absolutely be falsely elevated, and the list of conditions that push the number higher than it should be is longer than most people realize. Iron deficiency anemia is the most commonly reported culprit, but vitamin B12 deficiency, certain hemoglobin variants, chronic alcohol use, and even your racial or ethnic background can create a gap between what your A1c says and what your blood sugar is actually doing. The practical stakes are real: a falsely high reading can lead to an unnecessary diabetes diagnosis, medication changes you don’t need, or anxiety about glucose control that is actually fine.
Why A1c Depends on Red Blood Cell Lifespan
To understand how the number goes wrong, you need one key fact about how it’s generated. Hemoglobin A1c forms slowly as glucose in your bloodstream attaches to hemoglobin molecules inside red blood cells. This attachment is continuous and irreversible, accumulating over the roughly 120-day lifespan of each red blood cell.1PubMed Central. The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo The lab result reflects an average of glycation across red blood cells of all ages, from brand-new to near the end of their life. Anything that changes how long your red blood cells survive, how quickly new ones are produced, or how the hemoglobin molecule itself behaves can shift the A1c reading without any change in actual blood sugar.
The rule of thumb is straightforward: conditions that extend red blood cell lifespan or slow red cell turnover give glucose more time to attach, pushing A1c up. Conditions that shorten red blood cell lifespan or speed up turnover do the opposite, pulling A1c down.2PubMed Central. Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading False elevation is particularly concerning because it can make a healthy person look prediabetic or a well-controlled diabetic look poorly managed.
Iron Deficiency Anemia Is the Most Common Offender
Iron deficiency anemia is the single most frequently cited cause of falsely elevated A1c. When your body lacks iron, it produces fewer new red blood cells, and the ones already circulating tend to stick around longer. That extended lifespan means more time for glucose to attach to hemoglobin, inflating the number. But the mechanism goes beyond just aging cells. Iron deficiency also appears to change the hemoglobin molecule’s structure in ways that promote glycation, and it triggers oxidative stress that may accelerate the glycation process further.3PubMed Central. Increased Levels of Glycated Hemoglobin A1c and Iron Deficiency Anemia: A Review
Studies in both people with and without diabetes have shown that treating the iron deficiency brings A1c back down, even though blood sugar levels haven’t changed.2PubMed Central. Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading This matters most for people hovering near diagnostic cutoffs. If your A1c reads 6.0% and you have untreated iron deficiency, the “real” number could be meaningfully lower, potentially below the 5.7% threshold that separates normal from prediabetes.
Vitamin B12 Deficiency Can Mimic Prediabetes
B12 deficiency works through a similar mechanism. Without enough B12, your bone marrow can’t produce red blood cells at a normal rate. The cells that are in circulation age longer, accumulate more glycation, and drive the A1c reading upward. A study of patients with B12 deficiency anemia found that after three months of B12 replacement therapy, A1c dropped by about 0.24 percentage points on average, even though the patients’ underlying glucose metabolism hadn’t changed. Roughly 35% of the patients who initially looked prediabetic by A1c criteria were reclassified as normal after B12 treatment.4PubMed Central. Relationship between glycosylated hemoglobin and vitamin B12 deficiency anemia
That’s a striking number. More than a third of these patients would have been told they were prediabetic based on a lab result that was entirely an artifact of their vitamin deficiency. Folate deficiency produces the same type of anemia and likely has a similar effect, though it is less studied in this specific context.
Hemoglobin Variants and the Assay Problem
Hemoglobin comes in more varieties than most people know. The standard form is hemoglobin A, which is what A1c tests are designed to measure. But millions of people carry variant forms like hemoglobin S (associated with sickle cell trait), hemoglobin C, or hemoglobin E. These variants can interfere with the laboratory methods used to measure A1c, sometimes pushing the result up and sometimes pulling it down, depending on which variant you carry and which lab technique is used.
The two most common lab methods measure A1c differently. One separates hemoglobin types by their chemical properties (HPLC), while the other uses antibodies that bind to glycated hemoglobin (immunoassay). Each can be fooled in different ways. For example, hemoglobin S trait tends to produce artificially high readings on certain immunoassay platforms, because the amino acid change near the glycation site alters how the antibody binds.5PubMed Central. Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements In one case report, a patient with a previously undiagnosed hemoglobin C trait had a point-of-care A1c reading of 10.8% and a central lab reading of 9.2%, while continuous glucose monitoring showed an average glucose consistent with an A1c closer to 7%.6PubMed Central. Use of Continuous Glucose Monitoring Leads to Diagnosis of Hemoglobin C Trait in a Patient with Discrepant Hemoglobin A1c and Self-Monitored Blood Glucose
Another case involving a rare variant called Hb Sitia showed a lab A1c of 9.2% while continuous glucose monitoring data indicated a glucose management indicator of just 6.0%, a discordance of over three percentage points.7AACE Endocrinology and Diabetes. Discordance Between HbA1c and Continuous Glucose Monitoring Due to Hemoglobin Variant: A Case Report of Hb Sitia [HbB c.386C>T (p.Ala129Val)] These are not subtle laboratory curiosities. They represent real patients who could receive incorrect treatment based on a number that fundamentally misrepresents their glucose control.
Racial and Ethnic Differences That Are Not Explained by Blood Sugar
One of the more uncomfortable findings in this area is that A1c levels vary by race and ethnicity even after adjusting for actual blood glucose. In a large study of nearly 4,000 individuals, A1c was significantly higher in Black, Hispanic, American Indian, and Asian participants compared with White participants at the same glucose levels. After adjusting for a wide range of factors including fasting and post-meal glucose, insulin resistance, blood pressure, and hematocrit, adjusted A1c was about 5.8% in White participants compared with 6.2% in Black participants.8PubMed Central. Racial and Ethnic Differences in the Relationship between HbA1c and Blood Glucose: Implications for the Diagnosis of Diabetes
A separate cross-sectional analysis found that A1c levels were higher in Black participants across the board, by about 0.13 to 0.47 percentage points depending on glucose tolerance status, even after accounting for plasma glucose and other known correlates.9PubMed. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies Research in youth with type 1 diabetes has confirmed similar patterns, with Black youth showing higher A1c than White or South Asian youth at the same average blood glucose levels.10PubMed Central. Ethnic disparities in HbA1c and hypoglycemia among youth with type 1 diabetes: beyond access to technology, social deprivation and mean blood glucose
The reasons aren’t fully understood. Differences in red blood cell lifespan, glycation rates, or hemoglobin variants that are more common in certain populations may all contribute. What’s clear is that using the same A1c cutoffs across all racial groups may overdiagnose diabetes in some populations and underdiagnose it in others. Whether to call this “falsely elevated” or simply “biologically different” is a matter of framing, but the practical effect is the same: a Black patient and a White patient with identical glucose control may receive different diagnoses based on A1c alone.
Pregnancy Amplifies the Iron-Deficiency Effect
Pregnant women are especially vulnerable to falsely elevated A1c because pregnancy naturally increases iron demand. Iron stores get depleted rapidly, and iron deficiency in pregnancy has a stronger effect on A1c than the same degree of iron deficiency outside pregnancy. Research comparing pregnant and non-pregnant women found that iron-deficient pregnant women had significantly higher A1c than those with adequate iron stores, while no such difference showed up in non-pregnant women with the same iron status.11PubMed Central. Influence of Iron Deficiency on HbA1c Levels in Pregnant Women: Comparison with Non-Pregnant Women This creates a genuine clinical problem, since gestational diabetes screening is critical and a falsely high A1c could lead to unnecessary interventions.
Alcohol, Aspirin, and Other Substances
Chronic alcohol use can push A1c readings upward because alcohol’s breakdown product, acetaldehyde, forms a complex with hemoglobin that some assays can’t distinguish from glycated hemoglobin.12Postgraduate Medical Journal. Is HbA1c an ideal biomarker of well-controlled diabetes? Lab testing has confirmed that ethanol above certain concentration thresholds can cause measurably higher A1c readings, particularly in HPLC-based assays.13PubMed. Interference Assessment for High-Performance Liquid Chromatography HbA1c Assays
High-dose aspirin taken chronically can acetylate hemoglobin, which interferes with certain A1c assay methods. One study found a small increase of about 0.17 percentage points in people taking 200 mg of aspirin daily for four months, though a follow-up study using a different assay method did not replicate the finding. In practice, this is likely only a concern at large doses taken over extended periods.14PubMed Central. Drugs affecting HbA1c levels High-dose vitamins C and E, by contrast, do not appear to affect A1c readings.15Clinica Chimica Acta. The effect of aspirin and vitamins C and E on HbA1c assays
Severe hypertriglyceridemia (very high blood fats) and severe hyperbilirubinemia (high bilirubin, often from liver disease) have also been reported to cause false A1c elevations, though these are rarer and typically flagged by other abnormal lab work.16PubMed Central. Led Astray by Hemoglobin A1c: A Case of Misdiagnosis of Diabetes by Falsely Elevated Hemoglobin A1c Endogenous cholic acid (a bile acid) and low sample pH have also been shown to produce falsely high readings in HPLC systems.13PubMed. Interference Assessment for High-Performance Liquid Chromatography HbA1c Assays
Kidney Disease and Carbamylation
Kidney disease has long been suspected of distorting A1c readings, because uremia (the buildup of waste products in the blood) causes carbamylation of proteins, including hemoglobin. Carbamylated hemoglobin can look like glycated hemoglobin to certain lab assays, potentially inflating the reading. However, the actual evidence suggests this interference is smaller than once feared. A study evaluating multiple A1c measurement methods across different kidney function levels found that while some methods showed statistically significant effects, none showed clinically meaningful distortion.17PubMed Central. Measurement of HbA1c in patients with chronic renal failure A separate study confirmed a weak influence of carbamylation across three different measurement methods.18PubMed. Impact of carbamylation on three different methods, HPLC, capillary electrophoresis and TINIA of measuring HbA1c levels in patients with kidney disease
That said, kidney disease affects A1c through other pathways too. Patients on dialysis often receive erythropoietin (EPO) to stimulate red blood cell production, and the resulting surges in new red cells can drive A1c downward, since younger cells have had less time to accumulate glycation. Conversely, when EPO doses are reduced and cell turnover slows, A1c can drift upward independently of glucose levels.19PubMed. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis For people with advanced kidney disease, A1c should always be interpreted cautiously and alongside other measures of glucose control.
How to Spot a Falsely Elevated Result
The biggest red flag is a mismatch between what your A1c says and what your actual glucose readings show. If you check your blood sugar regularly with a meter or wear a continuous glucose monitor (CGM) and those numbers look well-controlled, but your A1c comes back high, something may be off with the A1c rather than with your glucose management.
CGM data has become an increasingly useful check. The glucose management indicator (GMI), calculated from CGM readings, provides an alternative estimate of what your A1c “should” be based on sensor glucose data. In a modeling study of people with type 1 diabetes, GMI explained about 69% of the variance in actual A1c, and incorporating prior discordance patterns improved accuracy further.20PLOS Digital Health. Narrowing the A1c gap: Personalized modeling of HbA1c– continuous glucose monitor discordance in type 1 diabetes When the gap between GMI and lab A1c is large, it’s worth investigating whether a hemoglobin variant, anemia, or other confounding factor explains the difference.
Some researchers have formalized this concept as the “hemoglobin glycation index,” defined as the gap between measured A1c and the A1c you’d predict from sensor glucose data. People whose A1c consistently runs higher than their glucose predicts are classified as “high glycators.”21PubMed Central. The Association of High and Low Glycation With Incident Diabetic Retinopathy in Adults With Type 1 Diabetes Whether this reflects a genuine biological tendency to glycate hemoglobin faster or an artifact of the conditions described above is still debated.
Alternative Blood Sugar Markers When A1c Is Unreliable
When you know or suspect that A1c is being distorted, alternative markers can fill the gap. Fructosamine measures glycation of serum proteins (mostly albumin) rather than hemoglobin, reflecting average blood sugar over roughly two to three weeks rather than two to three months. Because it doesn’t depend on red blood cell lifespan at all, it sidesteps the entire category of problems caused by anemias, hemoglobin variants, and turnover differences.22PubMed Central. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes
Glycated albumin (GA) is a more refined version of the same idea, specifically measuring the percentage of albumin that has been glycated. It’s particularly useful in the conditions that most commonly distort A1c: anemias, blood loss, kidney-related anemia, pregnancy, and liver cirrhosis. GA also responds more quickly to changes in glucose control, making it a better tracker when glycemia is shifting rapidly.23Annals of Pediatric Endocrinology & Metabolism. Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol Fructosamine has its own blind spots, though. It’s unreliable when albumin levels are abnormal, such as in nephrotic syndrome or severe liver disease, and it has more measurement-to-measurement variability than A1c, which means a single reading is less dependable.
When A1c Goes the Other Direction
It’s worth knowing that some conditions push A1c falsely low rather than falsely high, because the diagnostic consequences can be just as serious. Any condition that shortens red blood cell lifespan or accelerates turnover removes older, heavily glycated cells from circulation and replaces them with young cells that haven’t had time to accumulate glycation. Hemolytic anemias, significant blood loss, recent blood transfusions, and EPO therapy can all produce this effect. One case report described a patient with type 2 diabetes whose blood glucose readings ranged between roughly 145 and 270 mg/dL, yet his A1c was consistently below 27 mmol/mol (about 4.6%), a level that would be unusually low even for someone without diabetes. The cause turned out to be hypersplenism from chronic liver disease, with his enlarged spleen destroying red blood cells prematurely.24BMJ Case Reports. Falsely low glycosylated haemoglobin levels probably secondary to hypersplenism in a patient with diabetes mellitus The early research establishing how A1c forms actually noted this pattern: patients with shortened red blood cell lifespan due to hemolysis had markedly decreased A1c levels.1PubMed Central. The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo
A falsely low reading might seem like good news, but it can mask dangerously poor glucose control and delay treatment. For anyone with a condition that affects red blood cell turnover in either direction, A1c should never be the sole basis for clinical decisions. Pairing it with fructosamine, glycated albumin, or CGM data gives a much more complete and reliable picture.